Zimmer Biomet Holdings, Inc.

ZBH · Healthcare · · USD

91.39 USD

+0.00 (2.42%)

● Updated 2026-07-10 18:08 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score HOLD Mid-term (Position)

/ 100

Technical 75

Trend & RS 55

Momentum 54

Fundamental 68

Macro 65

Liquidity 32

Component	Score	Weight
Technical	75.0	20%
Trend & RS	54.9	30%
Momentum	53.9	15%
Fundamental	68.0	10%
Macro	65.2	20%
Liquidity	32.5	5%

Trade Setup

Entry	91.31
Stop Loss	85.85 (6.0%)
Target 1 (1:1)	96.77 (+6.0%)
Target 2 (2:1)	102.23 (+12.0%)

ATR(14)	2.73 (3.0%)
Risk per Share	5.46
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	74.2	+0.97
Momentum	53.9	+0.16
Quality	35.2	-0.59
Composite	54.4

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 2.91 — Grey Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	23.7	22.0	Inline
P/B Ratio	1.4	4.0	Below
Dividend Yield	1.1%	1.5%	Below avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

64.94

Market Price

91.39

Upside

-28.9%

Margin of Safety	-40.7%
Stage 1 PV (5yr FCF)	3,011,815,223
Terminal Value PV	9,551,088,640
Total Enterprise Value	12,562,903,863

Assumptions

Base FCF	597,412,144
Growth Rate (5yr)	9.3%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

40.1%

Full Kelly

20.05%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 61/100. Estimated win rate 58%, avg win 8.7%, avg loss 3.8%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

57.4

RSI(14)

0.7829

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-12.5% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (60d since high)
Sector Outperformance	-6.9% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	57.4	NEUTRAL
Macd	0.7829	BULLISH
Ma Cross	85.74 / 91.08	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.13x	LOW

Key Levels

Level	Price
52-Week High	108.29
Bollinger Upper	92.83
SMA(200)	91.08
SMA(50)	85.74
SMA(20)	88.59
Current Price	91.39
Bollinger Lower	84.35
52-Week Low	79.12
ATR(14)	2.73

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	1.11x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.74x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.73x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.81x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.13x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	88.30	Below Kijun
Kijun-sen (26)	88.31	Base line
Senkou A	88.31	Leading span A
Senkou B	86.22	Leading span B
Cloud	86.22 – 88.31	Bullish (Green)
Price vs Cloud	91.31	Above Cloud
Chikou Span	84.75	Bullish
Alignment Score	3/4	BULLISH